MATRICELF LTD
General Data
Reg Number
516016037
Sector
Biomed
Established
2019
No. of Employees
15
Stage
R&D
Additional Funding
0
Description
Matricelf’s novel regenerative medicine platform aims to cure a range of medical conditions , currently focusing on Spinal Cord Injuries (SCI)
Technology
Proprietary autologous 3D tissue engineering platform.
Targeted Customers
Healthcare & Biotechnology sectors, including regenerative medicine and cell-based therapies; Patients with spinal cord injuries and other severe tissue damage; Potential broader markets: neurological injuries, cardiovascular damage, trauma care.
Management personnel
Winning details
Route name
Winning year
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024